Global Health Partnerships : The Pharmaceutical Industry and BRICA

An exploration into the current status and future growth of the global pharmaceutical industry and the changing needs of global health. It provides comprehensive coverage of the role of the global pharmaceutical industry in general, and the participation of BRICAs in specific, to address global health needs. The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never been more urgent. The decrease of profits in pharmaceutical markets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India, China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnership model between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations Front Matter....Pages i-x Global Health Partnerships: An Introduction....Pages 1-32 The Modern Pharmaceutical Industry: History, Current Position and Challenges....Pages 33-80 BRICA in Global Pharmaceutical Provision....Pages 81-132 Global Health Partnerships between Multinationals and BRICA: A Planting Strategy....Pages 133-166 Back Matter....Pages 167-193